CCNA2 and non-small cell lung carcinoma: These results suggest that the DUB3–cyclin A axis plays a key role in G1/S transition during cell cycle progression and at least partially explain the mechanism of DUB3 which promotes the proliferation of NSCLC cells, providing a promising target for NSCLC treatment [85].